|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
ES2804472T3
(es)
|
2005-12-13 |
2021-02-08 |
Harvard College |
Estructuras para trasplante celular
|
|
WO2009002401A2
(en)
|
2007-06-21 |
2008-12-31 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
SI2222710T1
(sl)
|
2007-12-24 |
2016-11-30 |
Id Biomedical Corporation Of Quebec |
Rekombinatni RSV antigeni
|
|
JP5690143B2
(ja)
|
2008-02-13 |
2015-03-25 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
持続的細胞プログラミング装置
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
SG10201500161XA
(en)
*
|
2008-12-09 |
2015-03-30 |
Novavax Inc |
Modified rsv f proteins and methods of their use
|
|
CN102548578A
(zh)
|
2009-06-24 |
2012-07-04 |
魁北克益得生物医学公司 |
疫苗
|
|
WO2010149745A1
(en)
*
|
2009-06-24 |
2010-12-29 |
Glaxosmithkline Biologicals S.A. |
Recombinant rsv antigens
|
|
US20120164176A1
(en)
|
2009-07-15 |
2012-06-28 |
Kurt Swanson |
Rsv f protein compositions amd methods for making same
|
|
JP5646620B2
(ja)
*
|
2009-07-17 |
2014-12-24 |
インダストリー アカデミック コーポレーション ファウンデーション， ハルリム ユニバーシティー |
リポソームに被包されたオリゴヌクレオチド及びエピトープを含む免疫増強用組成物
|
|
CA2768552A1
(en)
*
|
2009-07-31 |
2011-02-03 |
President And Fellows Of Harvard College |
Programming of cells for tolerogenic therapies
|
|
CA2770304C
(en)
*
|
2009-08-04 |
2019-11-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention |
Anti-rsv immunogens and methods of immunization
|
|
JP5890407B2
(ja)
|
2010-07-07 |
2016-03-22 |
アーティフィシャル セル テクノロジーズ インコーポレイテッド |
呼吸器合胞体ウイルス抗原組成物および方法
|
|
JP6104806B2
(ja)
|
2010-10-06 |
2017-03-29 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
|
|
EP2668282A2
(en)
*
|
2011-01-28 |
2013-12-04 |
MedImmune, LLC |
Expression of soluble viral fusion glycoproteins in mammalian cells
|
|
EP2701734B1
(en)
*
|
2011-04-26 |
2019-09-25 |
Molecular Express, Inc. |
Liposomal formulations
|
|
WO2012149358A1
(en)
|
2011-04-28 |
2012-11-01 |
President And Fellows Of Harvard College |
Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
DK3275892T3
(da)
|
2011-05-13 |
2020-04-06 |
Glaxosmithkline Biologicals Sa |
Præfusions-rsv-f-antigener
|
|
US9486512B2
(en)
|
2011-06-03 |
2016-11-08 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
JP6085886B2
(ja)
|
2011-08-29 |
2017-03-01 |
国立大学法人徳島大学 |
Ｒｓｖ粘膜ワクチン
|
|
CA2849471A1
(en)
*
|
2011-09-30 |
2013-04-04 |
Novavax, Inc. |
Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
|
|
WO2013155205A1
(en)
*
|
2012-04-10 |
2013-10-17 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
|
|
EP3662896B1
(en)
|
2012-04-16 |
2024-02-28 |
President and Fellows of Harvard College |
Mesoporous silica compositions for modulating immune responses
|
|
CA3158572A1
(en)
|
2012-08-01 |
2014-02-06 |
Bavarian Nordic A/S |
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
|
|
PT2879702T
(pt)
*
|
2012-08-01 |
2020-02-04 |
Bavarian Nordic As |
Vacina para o vírus sincicial respiratório (rsv) de vírus vaccinia modificado recombinante ankara (mva)
|
|
US20140037680A1
(en)
*
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
AU2013301312A1
(en)
|
2012-08-06 |
2015-03-19 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against RSV and B. pertussis
|
|
US20140227309A1
(en)
*
|
2013-02-11 |
2014-08-14 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
CN105555304A
(zh)
|
2013-08-05 |
2016-05-04 |
葛兰素史密丝克莱恩生物有限公司 |
联合免疫原性组合物
|
|
US10682400B2
(en)
|
2014-04-30 |
2020-06-16 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
EP3154576A1
(en)
|
2014-06-13 |
2017-04-19 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic combinations
|
|
US11786457B2
(en)
|
2015-01-30 |
2023-10-17 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
CN107708756A
(zh)
|
2015-04-10 |
2018-02-16 |
哈佛学院院长等 |
免疫细胞捕获装置及其制备和使用方法
|
|
CA2996007A1
(en)
|
2015-09-03 |
2017-03-09 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
AU2016379097C1
(en)
|
2015-12-23 |
2021-04-08 |
Pfizer Inc. |
RSV F protein mutants
|
|
JP7138864B2
(ja)
|
2016-02-06 |
2022-09-20 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
免疫を再構成するための造血ニッチの再現
|
|
CN115305229B
(zh)
|
2016-07-13 |
2025-08-19 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
WO2018026884A1
(en)
|
2016-08-02 |
2018-02-08 |
President And Fellows Of Harvard College |
Biomaterials for modulating immune responses
|
|
EP3494226B1
(en)
|
2016-08-03 |
2021-09-22 |
Lonza Walkersville, Inc. |
Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
CN110192110B
(zh)
*
|
2017-01-11 |
2023-01-10 |
隆萨沃克斯维尔股份有限公司 |
无凝固蛋白原的澄清的鲎阿米巴样细胞裂解物
|
|
WO2019023196A1
(en)
|
2017-07-24 |
2019-01-31 |
Novavax, Inc. |
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
|
|
AR114989A1
(es)
|
2017-10-16 |
2020-11-18 |
Glaxosmithkline Biologicals Sa |
Vectores adenovirales con dos casetes de expresión
|
|
JP2020537526A
(ja)
|
2017-10-16 |
2020-12-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Ｒｓｖ抗原性タンパク質又はその断片をコードする２つの発現カセットを有するアデノウイルスベクター
|
|
BR112020007042A2
(pt)
|
2017-10-16 |
2020-11-17 |
Glaxosmithkline Biologicals S.A. |
promotor intensificado
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
SG11202009206QA
(en)
|
2018-03-19 |
2020-10-29 |
Novavax Inc |
Multivalent influenza nanoparticle vaccines
|
|
CA3102224A1
(en)
|
2018-06-12 |
2019-12-19 |
Glaxosmithkline Biologicals Sa |
Chimpanzee adenovirus chad157 polynucleotides, polypeptides.vectors, compositions, cells and uses thereof
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
EP3932424A4
(en)
|
2019-02-28 |
2022-10-12 |
KM Biologics Co., Ltd. |
Rsv f/g chimeric vaccine
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|